Estimating the 95% effective defibrillation dose

Area of Science:

• Biomedical Engineering
• Medical Device Testing
• Cardiac Electrophysiology

Background:

• Accurate estimation of the effective defibrillation dose 95 (ED95) is crucial for implantable defibrillator efficacy.
• Existing methods may lack precision in determining the optimal voltage for successful defibrillation.
• Standardized and reliable testing protocols are needed for device calibration.

Purpose of the Study:

• To introduce Minimum Squared Error (MinSE) testing protocols and an estimator for accurate ED95 determination.
• To validate the MinSE approach using a prospective study with implantable defibrillator electrodes and biphasic waveforms.
• To assess the impact of population distribution assumptions on ED95 estimation accuracy.

Main Methods:

• Development of MinSE testing protocols presented as lookup tables for successful and unsuccessful defibrillation trials.
• Utilizing statistical analysis for dose-response curve selection and ED95 population distribution assumptions.
• Prospective study involving five dogs with nonthoracotomy implantable defibrillator electrodes and biphasic waveforms.

Main Results:

• The MinSE estimator achieved a measured root-mean-square error of 15% of the mean ED95 for four test shocks.
• ED95 estimation accuracy improved by 3.8% when population distribution assumptions were specific to species, size, and device parameters.
• The MinSE approach demonstrated its applicability to various defibrillation parameter estimation challenges.

Conclusions:

• MinSE protocols and estimators provide accurate and reliable methods for determining the ED95 for defibrillation.
• The accuracy of ED95 estimates can be further enhanced by refining population distribution assumptions.
• The MinSE approach offers a flexible framework extendable to diverse defibrillation testing scenarios.